Olipharma

Olipharma was founded in 2021, focusing on providing "one-stop" CDMO services for global pharmaceutical companies, including nucleic acid drug discovery, laboratory R&D, process and analytical development, CMC services, API production, and drug registration. It meets customers' diverse process R&D needs from preclinical to commercial stages, shortening project timelines and accelerating the progress of nucleic acid drugs from discovery to commercial production and market launch.